At a recent campaign stop, President Trump informed supporters that he “felt like Superman” after his experimental COVID-19 treatment with a Regeneron Pharmaceuticals Inc. antiviral drug.
The antiviral drug may have resulted...more
10/30/2020
/ Coronavirus/COVID-19 ,
Enablement Inquiries ,
EU ,
European Patent Office ,
Life Sciences ,
Patent Infringement ,
Patent Invalidity ,
Patent Validity ,
Patented Medicines ,
Pharmaceutical Patents ,
Popular ,
Regenerative Medicine ,
Regeneron ,
UK ,
UK Supreme Court